13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 60 holding rows worth $209,146,246.
- Accession
- 0001420506-26-000376
- Filer
- CIK 2011932
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 60 entries on the cover page, a total value of $209,146,246 stated on the cover page (in dollars after the unit check, H1), rows summing to $209,146,246 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 58,122 | $17,130,878 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 305,568 | $10,853,775 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 98,182 | $10,028,309 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 116,515 | $9,217,502 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 7,852 | $8,438,387 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 124,749 | $7,926,551 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 421,488 | $7,165,296 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 124,391 | $6,299,160 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 80,723 | $6,174,502 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 17,191 | $6,026,305 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 28,362 | $5,260,652 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 26,494 | $4,503,980 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 18,650 | $4,272,529 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 158,622 | $4,032,171 | dollars as filed | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 17,628 | $3,843,257 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 7,685 | $3,744,516 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 136,942 | $3,727,561 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 46,743 | $3,711,862 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 6,358 | $3,600,917 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 31,471 | $3,553,391 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 222,308 | $3,423,543 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 34,289 | $3,419,985 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 135,849 | $3,412,527 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 89,052 | $3,402,677 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 50,147 | $3,328,256 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 49,758 | $3,303,434 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 745,305 | $3,174,999 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 91,148 | $3,143,695 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 401,743 | $3,101,456 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G957 | PUT | 74,700 | $2,854,287 | dollars as filed | put |
| ALUMIS INC | 022307102 | COM | 292,250 | $2,852,360 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 9,000 | $2,798,190 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 163,658 | $2,669,262 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 76,750 | $2,663,993 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 100,046 | $2,482,641 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 165,000 | $2,341,350 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 14,328 | $2,291,907 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 68,969 | $2,258,735 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 648,532 | $2,185,553 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 295,541 | $2,175,182 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 1,060,221 | $2,003,818 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 499,587 | $1,988,356 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 5,835 | $1,926,192 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 758,203 | $1,781,777 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 64,845 | $1,760,542 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 451,699 | $1,400,267 | dollars as filed | |
| DISC MEDICINE INC | 254604951 | PUT | 16,000 | $1,270,560 | dollars as filed | put |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 600,000 | $1,230,000 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 5,378 | $1,212,255 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 6,084 | $1,209,012 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 139,543 | $1,135,880 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 92,055 | $1,041,142 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 13,100 | $954,728 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D958 | COM | 35,200 | $809,600 | dollars as filed | call |
| ALUMIS INC | 022307952 | COM | 53,200 | $519,232 | dollars as filed | put |
| ALDEYRA THERAPEUTICS INC | 01438T906 | COM | 100,000 | $518,000 | dollars as filed | call |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 14,194 | $480,751 | dollars as filed | |
| PRECIGEN INC | 74017N955 | COM | 100,000 | $418,000 | dollars as filed | put |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 75,484 | $363,078 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203959 | PUT | 7,100 | $327,523 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-000376 | this filing | 2026-02-13 | acceptance time not in the bulk data set |